We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 14 SEPTEMBER 2007
Federal Circuit Makes D.C. Swallow its Own Medicine
McDermott Will & Emery
The U.S. Court of Appeals for the Federal Circuit affirmed a district court’s ruling that the District of Columbia’s Prescription Drug Excessive Pricing Act of 2005 (the Act) is preempted by federal patent laws and facially unconstitutional as invalidated by the Commerce Clause of the United States Constitution.
United StatesIntellectual Property








